Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
M2GEN Expands World-Class Executive Leadership Team Appoints Melissa Honour, MPH, as Chief Product Officer
M2GEN, a bioinformatics company accelerating discoveries in oncology research through industry-leading data and analytics, today announced […]
Halo Labs Completes $6M Series C Growth Financing
Halo Labs, a leading life science instrumentation company announced it has raised $6M in series C financing. […]
Centauri Therapeutics Strengthens Senior Leadership Team With Three Key Appointments
Centauri Therapeutics Limited (Centauri), an immunotherapy company focused on the treatment of infectious diseases, today […]
Overjet Partners with Affinity Dental Management to Improve Lives through AI
Overjet announced today it has partnered with Affinity Dental Management to provide its practices with […]
Concord Health Partners Adds Healthcare Veteran Brian Gragnolati as Executive Partner
Concord Health Partners (“Concord” or the “Firm”), a healthcare focused investment firm, today announced that […]
ABL Partners With KaliVir Immunotherapeutics to Advance Development of Oncolytic Viruses
ABL, a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and […]
Nosopharm Welcomes New Members To Supervisory Board
Nosopharm, specialized in exploring unconventional sources of antibiotics to discover new drugs to fight antimicrobial resistance, […]
CVS Health Names Tilak Mandadi Executive Vice President and Chief Data, Digital and Technology Officer
CVS Health (NYSE: CVS) has appointed Tilak Mandadi as Executive Vice President and to the newly created role […]
HKUMed and CityU Scientists Discover Non-invasive Stimulation of the Eye for Depression and Dementia
A joint research team from Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed) […]
EarlySign Announces Strategic Collaboration Agreement with Roche on AI Solution for Early Detection of Lung Cancer
Medial EarlySign (earlysign.com), a pioneering company developing Artificial Intelligence (AI) based clinical predictive analytics, announced today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more